Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): Consensus on Obesity and Cardiometabolic Comorbidities in Inflammatory Bowel Disease using Evidence Synthesis and the RAND/UCLA Appropriatene
CRD420251178843: A systematic review of the impact of obesity on inflammatory bowel disease outcomesCRD420251178799 : A Systematic Review of Cardiometabolic Complications in Inflammatory Bowel DiseaseCRD420251174653 : Management of Overweight, Obesity, and Cardiometabolic Comorbidities in Inflammatory Bowel Disease: A Systematic Review.
Authors
- Michelle Doering (ORCID: https://orcid.org/0000-0001-6664-8924)
- Parakkal Deepak (ORCID: https://orcid.org/0000-0002-3436-9784)
- Mouhand Mohamed (ORCID: https://orcid.org/0000-0002-4761-8014)
- Shannon Coombs (ORCID: https://orcid.org/0000-0002-1591-1507)
- Sami Samaan
- Priya Sehgal (ORCID: https://orcid.org/0000-0003-2611-2767)
- Jalpa Devi
- EDWARD L BARNES
- AMANDA M JOHNSON
- Matthew VINCENT
- ANDRES J YARUR
Institutions
- University of North Carolina at Chapel Hill (US)
- Cedars-Sinai Medical Center (US)
- Washington University in St. Louis (US)
- Thomas Jefferson University Hospital (US)
- Mayo Clinic in Arizona (US)
- Cedars-Sinai Smidt Heart Institute (US)
- Saint Louis University (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- medRxiv
- Published
- 2025-12-22
- DOI
- https://doi.org/10.64898/2025.12.20.25342738
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00